Investigación
Single Euploid Embryo Transfer Outcomes After Uterine Septum Resection
- 2025
Dra. Tamar Alkon
Purpose: To determine whether the embryonic euploidy rate and live birth outcomes following single, euploid embryo transfer (SEET) differ among women of self-reported racial and ethnic backgrounds.
Correlation Of Self Reported Racial Background To Euploidy Status And Live Birth Rates In Assisted Reproductive Technology Cycle
- 2024
Dra. Tamar Alkon, Dra. Martha Luna
Study Objective: To study pregnancy outcomes after single euploid embryo transfer (SEET) in patients who underwent prior uterine septum resection to those with uteri of normal contour, without Müllerian anomalies or uterine abnormalities including polyps or fibroids, and without a history of prior uterine surgeries.
Effect Of Various Contraceptives On Oocyte Yield And Maturation In Patients Undergoing Planned Oocyte Cryopreservation: A Retrospective
- 2024
Dra. Tamar Alkon
Delayed child bearing has become commonplace in contemporary society. Advances in hormonal contraceptives have enabled women to pursue personal and professional pursuits while managing the initiation of childbearing. Some of these women will face unforeseen fertility issues while trying to conceive at an advanced age due to a compromised ovarian reserve and/or other infertility-related causes. Consequently, these patients may require assisted reproductive technique (ART) treatments, with a suboptimal prognosis. In some cases, ART may result in costly and time-consuming therapies that ultimately require donor gametes or the abandonment of treatment.
Recent Clomiphene Citrate Exposure Does Not Impact Subsequent Clinic
- 2023
Dra. Tamar Alkon
Study question: Do infertile couples who recently utilized clomiphene citrate (CC) for ovulation induction or ovarian stimulation (<90 days previously) followed by a single euploid embryo transfer (SEET) have lower implantation potential compared with patients who were not exposed to CC within 90 days before embryo transfer (ET)?
Biological relevance of trophectoderm morphology: initial β‑hCG measurements correlate with trophectoderm grading on euploid frozen embryo transfers
- 2022
Dra. Tamar Alkon
Objective: To analyze the correlation between TE grading and initial β-hCG serum level after single euploid embryo transfer. Secondarily, to explore the association between TE grading with subsequent IVF outcomes.
Parental Chromosomal Heteromorphism
- 2021
Dra. Tamar Alkon, Dra. Martha Luna
Objective: Although chromosomal heteromorphisms
are commonly found in the general population, some
researchers have suggested a correlation with higher rates of embryo aneuploidy. This study aimed to assess the rates of embryo aneuploidy in couples who carry a chromosome heteromorphism
The association between prior cesarean delivery and subsequent in vitro fertilization outcomes in women undergoing autologous, frozen-thawed single euploid embryo transfer
- 2021
Dra. Tamar Alkon, Dra. Martha Luna
Objective: This study aimed to investigate the relationship between the previous mode of delivery and subsequent pregnancy outcomes in patients undergoing a single frozen-thawed euploid embryo transfer after in vitro fertilization.
Late follicular phase progesterone elevation during ovarian stimulation is not associated with decreased implantation of chromosomally screened embryos in thaw cycles
- 2020
Dra. Tamar Alkon
STUDY QUESTION: What is the impact of a late follicular phase progesterone elevation (LFPE) during controlled ovarian hyperstimulation (COH) on embryonic competence and reproductive potential in thaw cycles Of preimplantation genetic testing for aneuploidy (PGT-A) screened embryos?
Expanded carrier screening for preconception reproductive risk assessment: Prevalence of carrier status in a Mexican population
- 2020
Dra. Tamar Alkon, Dra. Martha Luna
Objective: Genetic carrier screening has the potential to identify couples at risk of having a child affected with an autosomal recessive or X-linked disorder. However, the current prevalence of carrier status for these conditions in developing countries is not well defined. This study assesses the prevalence of carrier status of selected genetic conditions utilizing an expanded, pan-ethnic genetic carrier screening panel (ECS) in a large population of Mexican patients.